TRAW
TRAW
NASDAQ · Pharmaceuticals

Traws Pharma Inc

$0.22
+0.00 (+0.82%)
As of Nov 7, 2:46 AM ET ·
Financial Highlights (FY 2026)
Revenue
5.22M
Net Income
17.14M
Gross Margin
—
Profit Margin
328.7%
Rev Growth
+131.1%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — 34.9% 34.9% 34.9%
Operating Margin -640.7% 18.7% 18.2% 19.0%
Profit Margin 328.7% 13.2% 16.7% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.22M 4.81M 4.77M 3.83M
Gross Profit — 1.68M 1.66M 1.34M
Operating Income -33,418,285 901.1K 867.4K 727.7K
Net Income 17.14M 633.7K 796.1K 510.0K
Gross Margin — 34.9% 34.9% 34.9%
Operating Margin -640.7% 18.7% 18.2% 19.0%
Profit Margin 328.7% 13.2% 16.7% 13.3%
Rev Growth +131.1% +22.7% +21.0% +9.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 6.83M 5.75M 5.44M
Total Equity — 8.41M 8.92M 7.51M
D/E Ratio — 0.81 0.64 0.73
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -33,410,377 1.15M 1.15M 1.01M
Free Cash Flow — 870.8K 772.5K 534.0K